tiprankstipranks
Trending News
More News >
Calyx Bio-Ventures (TSE:CYX.H)
:CYX.H
Canadian Market

Calyx Bio-Ventures (CYX.H) Income Statement

Compare
7 Followers

Calyx Bio-Ventures Income Statement

Last quarter (Q0 0), Calyx Bio-Ventures's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Calyx Bio-Ventures's net income was $-133.68K. See Calyx Bio-Ventures’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 18Dec 17Dec 16Dec 15Dec 14
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 2.40K$ 54.05K$ 61.14K$ 33.05K$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 62.48K$ 133.45K$ 138.28K$ 112.67K$ 13.39K
EBITDA
$ -1.62M$ -918.45K$ -556.69K$ -39.17K$ -513.60K
Operating Income
$ -796.00K$ -1.06M$ -694.83K$ -450.99K$ -568.28K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -2.49M$ -1.45M$ -696.34K$ -151.85K$ -526.99K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Calyx Bio-Ventures Earnings and Revenue History